SCHEMBL174435

SCHEMBL174435

Cc1cc(Nc2nc(CO)nc3cccc(-c4ccc(F)cc4)c23)n[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 8/20 0.50
AURKB Q96GD4 5/20 0.50
NTRK1 P04629 7/20 0.49
JAK2 O60674 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C8 P10632 3/20 0.48
CYP2C9 P11712 3/20 0.48
JAK1 P23458 3/20 0.48
TYK2 P29597 3/20 0.48
CYP2C19 P33261 3/20 0.48
JAK3 P52333 3/20 0.48
ADORA3 P0DMS8 2/20 0.48
CYP1A2 P05177 1/20 0.48
SRC P12931 3/20 0.47
GSK3B P49841 3/20 0.47
EIF2AK2 P19525 1/20 0.47
GSK3A P49840 1/20 0.47
PLK4 O00444 1/20 0.45
PAK4 O96013 1/20 0.45
NTRK3 Q16288 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL174764 0.99 AURKA (0.49) AURKAAURKBNTRK1JAK2CYP3A4
SCHEMBL174782 0.91 NTRK1 (0.47) AURKAAURKBNTRK1JAK2CYP3A4
SCHEMBL14432758 0.84 NTRK1 (0.47) AURKAAURKBNTRK1JAK2CYP3A4
SCHEMBL187199 0.84 AURKA (0.52) AURKAAURKBNTRK1SRCGSK3B
SCHEMBL174676 0.84 PLK4 (0.45) AURKAAURKBNTRK1JAK2CYP3A4
SCHEMBL17501774 0.82 AURKA (0.53) AURKAAURKBNTRK1JAK2CYP3A4
SCHEMBL174948 0.81 SYK (0.42) AURKAAURKBNTRK1JAK2CYP3A4
SCHEMBL15232334 0.79 AURKA (0.76) AURKAAURKBNTRK1SRCGSK3B
Hydrochloric Acid SCHEMBL28561065 0.78 AURKA (0.74) AURKAAURKBNTRK1SRCGSK3B
SCHEMBL187921 0.77 NTRK1 (0.52) AURKAAURKBNTRK1JAK2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611796-A1 AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP claimed
WO-2012030917-A1 AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO claimed
WO-2013130600-A1 SOLID FORMS COMPRISING OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, COMPOSITIONS THEREOF, AND USES THEREWITH AMBIT BIOSCIENCES CORPORATION (US) 2013-09-06 WO disclosed
EP-2611796-A1 AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
EP-2611795-A1 AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030913-A1 AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
WO-2012030917-A1 AN OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed